| Company Name | Entity type | Parent/Subsidiary/Independent | Headquarters | No. of Employees | Annual Revenue ($M) | |
|---|---|---|---|---|---|---|
| Eli Lilly and Co | Public | Parent | United States of America | 43,000 | 34,124 | |
| Eli Lilly and Company (India) Pvt Ltd | Private | Subsidiary (of Eli Lilly and Co ) | India | XYZ | XYZ | |
| Eli Lilly Canada Inc | Private | Subsidiary (of Eli Lilly and Co ) | Canada | XYZ | XYZ | |
| Eli Lilly and Company Ltd | Private | Subsidiary (of Eli Lilly and Co ) | United Kingdom | XYZ | XYZ | |
| Eli Lilly Benelux SA | Private | Subsidiary (of Eli Lilly and Co ) | Belgium | XYZ | XYZ | |
| DexCom Inc | Public | Parent | United States of America | 9,600 | 3,622 | |
| Eli Lilly and Company (Taiwan) Inc | Private | Subsidiary (of Eli Lilly and Co ) | Taiwan | XYZ | XYZ | |
| Lilly's Cakes | Private | Independent | Belgium | XYZ | XYZ | |
| Halozyme Therapeutics Inc | Public | Parent | United States of America | 373 | 829 | |
| PDL BioPharma Inc | Private | Parent | United States of America | XYZ | XYZ | |
| Guardsman Industries Ltd | Private | Subsidiary (of The Amynta Group ) | United Kingdom | XYZ | XYZ | |
| Leap Therapeutics Inc | Public | Parent | United States of America | 54 | XYZ | |
| AC Immune SA | Public | Parent | Switzerland | 133 | 16 | |
| Rigel Pharmaceuticals Inc | Public | Independent | United States of America | 147 | 117 | |
| Nektar Therapeutics | Public | Parent | United States of America | 137 | 90 | |
| Physiomics Plc | Public | Independent | United Kingdom | 10 | 1 | |
| Lilly Pulitzer | Private | Independent | United States of America | XYZ | XYZ | |
| Antares Pharma Inc | Private | Subsidiary (of Halozyme Therapeutics Inc) | United States of America | 201 | 184 | |
| Lilly Hall LLC | Private | Independent | United States of America | XYZ | XYZ | |
| Lilly Asia ventures | Private | Subsidiary (of Eli Lilly and Co ) | China | XYZ | XYZ | |
| Lilly Korea Ltd | Private | Subsidiary (of Eli Lilly and Co ) | South Korea | XYZ | XYZ | |
| Lilly drogerie d.o.o. | Private | Independent | Serbia | XYZ | XYZ | |
| Eli Lilly Italia SpA | Private | Subsidiary (of Eli Lilly and Co ) | Italy | XYZ | XYZ | |
| Walter Lilly & Co Ltd | Private | Subsidiary (of Renew Holdings Plc ) | United Kingdom | XYZ | XYZ | |
| Eli Lilly Group Limited | Private | Subsidiary (of Eli Lilly and Co ) | United Kingdom | XYZ | XYZ | |
| Eli Lilly Asia Inc | Private | Subsidiary (of Eli Lilly and Co ) | Hong Kong | XYZ | XYZ | |
| J Richard Lilly & Associates | Private | Independent | United States of America | XYZ | XYZ | |
| Eli Lilly Japan KK | Private | Subsidiary (of Eli Lilly and Co ) | Japan | XYZ | XYZ | |
| Eli Lilly Australia Pty Ltd | Private | Subsidiary (of Eli Lilly and Co ) | Australia | XYZ | XYZ | |
| Eli Lilly (Malaysia) Sdn Bhd | Private | Subsidiary (of Eli Lilly and Co ) | Malaysia | XYZ | XYZ | |
| Eli Lilly Asia Fund (LAV) | Private | Independent | China | XYZ | XYZ | |
| Eli Lilly Singapore Pte Ltd | Private | Subsidiary (of Eli Lilly and Co ) | Singapore | XYZ | XYZ | |
| Lilly Ventures Management Co LLC | Private | Subsidiary (of Eli Lilly and Co ) | United States of America | XYZ | XYZ | |
| Lilly Asia Ventures Fund I LP | Institution | Subsidiary (of Eli Lilly and Co ) | China | XYZ | XYZ | |
| Eli Lilly and Co (NZ) Ltd | Private | Subsidiary (of Eli Lilly and Co ) | New Zealand | XYZ | XYZ | |
| Eli Lilly European Clinical Trial Services | Private | Independent | Belgium | XYZ | XYZ | |
| The Lilly TB Drug Discovery Initiative | Private | Subsidiary (of Eli Lilly and Co ) | United States of America | XYZ | XYZ | |
| Lilly China Research and Development Co Ltd | Private | Subsidiary (of Eli Lilly and Co ) | China | XYZ | XYZ | |
| Lilly Centre for Clinical Pharmacology Pte Ltd | Private | Subsidiary (of Eli Lilly and Co ) | Singapore | XYZ | XYZ | |
| Lillycover Co., Ltd. | Private | Independent | South Korea | XYZ | XYZ | |
| ImClone Systems Corp | Private | Subsidiary (of Eli Lilly and Co ) | United States of America | XYZ | XYZ | |
| Frasers Group plc | Public | Parent | United Kingdom | 32,481 | 6,849 | |
| ImClone Systems Inc | Private | Subsidiary (of Eli Lilly and Co ) | United States of America | XYZ | XYZ | |
| ImClone LLC | Private | Subsidiary (of Eli Lilly and Co ) | United States of America | XYZ | XYZ | |
| Ivy Animal Health Inc | Private | Subsidiary (of Eli Lilly and Co ) | United States of America | XYZ | XYZ | |
| Hydra Biosciences Inc | Private | Independent | United States of America | XYZ | XYZ | |
| Petra Pharma Corp | Private | Subsidiary (of Eli Lilly and Co ) | United States of America | XYZ | XYZ | |
| Oxford Industries Inc | Public | Parent | United States of America | XYZ | XYZ | |
| Renew Holdings Plc | Public | Parent | United Kingdom | XYZ | XYZ | |
| Akouos Inc | Private | Subsidiary (of Eli Lilly and Co) | United States of America | 103 | XYZ |
Top Companies
Major players identified by our expert analysts across different sectors, geographies and themes based on metrics like revenues, market cap, funding, and sector KPIs.
You have selected companies to view summary table
Thank You
Your request have been sent, a member of our team will be in touch.
Thank You
Signup notification message here.
Company Comparison
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer